N4 Pharma PLC (N4P) — Capital Reinvestment Ratio

Latest as of December 2011: 1.32x

N4 Pharma PLC (N4P) has a Capital Reinvestment Ratio of 1.32x as of December 2011, meaning it reinvests 1% of its operating cash flow (GBX496.50K) in capital expenditures (GBX655.00K). See debt-free asset ratio of N4 Pharma PLC to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.32x
Capex / Operating Cash Flow

Operating Cash Flow

GBX496.50K
GBX

Capital Expenditures

GBX655.00K
GBX

Data as of

Dec 2011
Most recent filing

N4 Pharma PLC Capital Reinvestment Ratio (1992–2011)

This chart tracks N4 Pharma PLC's Capital Reinvestment Ratio across 12 annual periods. Check N4P cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for N4 Pharma PLC (1992–2011)

Year-by-year Capital Reinvestment Ratio for N4 Pharma PLC from 1992 to 2011. For live market cap and broader valuation context, see N4 Pharma PLC market cap and net worth.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
2011 1.32x GBX996.00K GBX1.31 Million ▼ -30.2%
2010 1.88x GBX249.00K GBX469.00K ▲ +53.2%
2009 1.23x GBX755.00K GBX928.00K ▲ +2085.1%
2007 0.06x GBX160.00K GBX9.00K ▼ -87.5%
2004 0.45x GBX140.00K GBX63.00K ▼ -70.8%
2003 1.54x GBX85.00K GBX131.00K ▲ +1698.0%
2001 0.09x GBX210.00K GBX18.00K ▼ -95.3%
1996 1.82x GBX2.02 Million GBX3.67 Million ▼ -92.4%
1995 24.09x GBX163.00K GBX3.93 Million ▲ +2837.9%
1994 0.82x GBX3.34 Million GBX2.73 Million ▼ -69.2%
1993 2.66x GBX310.00K GBX824.00K ▲ +1046.6%
1992 0.23x GBX2.72 Million GBX631.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow